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Abstract
Background: Reimbursement systems provide incentives to health care providers and may drive physician
behaviour. This review assesses the impact of reimbursement system on socioeconomic and racial inequalities in
access, utilization and quality of primary care.
Methods: A systematic search was performed in Web of Science and PubMed for English language studies
published between 1980 and 2013, supplemented by reference tracking. Articles were selected based on inclusion
criteria, and data extraction and critical appraisal were performed by two authors independently. Data were
synthesized in a narrative manner and categorized according to study outcome and reimbursement system.
Results: Twenty seven articles, mostly from the United States and United Kingdom, were included in the data
synthesis. Reimbursement systems seem to have limited effect on socioeconomic and racial inequity in access,
utilization and quality of primary care. Capitation might have a more beneficial impact on inequity in access to
primary care and number of ambulatory care sensitive admissions than fee-for-service, but did worse in patient
satisfaction.
Pay-for-performance had little or no impact on socioeconomic and racial inequity in the management of diabetes,
cardiovascular diseases, chronic obstructive pulmonary disease, and preventive services.
Conclusion: We found little scientific evidence supporting an association between reimbursement system and
socioeconomic or racial inequity in access, utilization and quality of primary care. Overall, few studies addressed this
research question, and heterogeneity in context and outcomes complicates comparisons across studies. Further
empirical studies are warranted.
Keywords: Inequality, Healthcare disparities, Socioeconomic factors, Ethnic groups, Health services accessibility,
Quality of health care, Outcome assessment, Health policy, Reimbursement mechanisms, Capitation fee
Background
Socioeconomic and ethnic health inequities are one of
the main challenges to public health and well-
documented in scientific literature [1]. According to a
study of 22 European countries, low socioeconomic
status implied higher rates of death and poorer self-
assessed health [2]. There are significant differences in
chronic disease prevalence and mortality between racial
groups, such as cardiovascular disease, as evidenced by
studies from North America and the United Kingdom
(UK) [3–5]. Although health care can act as a vehicle for
reducing health inequalities in the population, there is
an abundance of literature indicating the existence of
socioeconomic and racial inequity in both access to care
and in the quality of care received. Based on the concep-
tual framework of the health care continuum by
Burstrom, inequities may arise at any stage of the
continuum [6]. In Fig. 1, we have extended this frame-
work with 'Quality of care' and 'Health outcome' where
inequities are also observed. In the United States (US),
patients with Medicaid insurance face difficulties in
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finding healthcare providers willing to accept them [7],
and low-income individuals with chronic conditions are
less likely to receive standard of care [8]. Fewer His-
panics and African Americans have a regular primary
care provider and they are more likely to visit the emer-
gency room. There is a widening racial gap in admis-
sions for ambulatory care sensitive conditions (ACSC),
indicating insufficient care in the outpatient setting [9,
10]. In Sweden, high income individuals aged 65+ have
significantly more doctor’s visits than low income indi-
viduals after adjustment for health status, and non-
attendance in breast cancer screening is associated with
disadvantaged socioeconomic position [11, 12].
Primary care has a central role in health care delivery,
and a strong primary care system has been shown to
reduce health inequalities [13, 14]. Funding mechanisms
of primary care might have direct and indirect implica-
tions for service delivery, and reimbursement systems
may create incentives to achieve policy objectives, such
as improving access to care, quality of care, cost contain-
ment and recruitment of physicians to underserved areas
[15]. As a result, the setup of reimbursement might
ameliorate or aggravate existing health care inequities.
Reimbursement through fee-for-service (provider is re-
imbursed per item of service) might improve access to
services, but can also increase the risk of overtreatment
[16]. Reimbursement through capitation (provider re-
ceives a periodical lump sum per listed patient irrespect-
ive of services provided) could encourage cost-effective
treatments and preventive services, but providers might
be inclined to undertreat patients or choose to list
healthier patients that jeopardizes access to care for vul-
nerable populations [17]. To mitigate some of these ef-
fects, reimbursement through capitation may be
adjusted for age, socioeconomic factors or disease diag-
nosis [18]. Reimbursement through pay-for-performance
(provider reimbursement is based on process and out-
come indicators of clinical relevance) aims to increase
quality of care and has been adopted as a complement
to other reimbursement practices in several countries
[19]. However, concerns have been raised that pay-for-
performance might increase inequity if health care
providers choose to treat patients that are more likely to
achieve favourable outcomes [20].
Available literature addressing the impact of reim-
bursement systems on health care inequity is inconsist-
ent. A systematic review on the impact of the Quality
and Outcomes Framework (QOF), a large pay-for-
performance scheme for primary care physicians in the
UK, concluded that existing inequalities in chronic
disease management largely persisted after implementing
pay-for-performance [19]. The impact of fee-for-service
and capitation on health care inequalities has not been
previously reviewed. Despite this knowledge gap, reim-
bursement to health care providers has been modified to
serve policy purposes. In 2010, a nationwide choice
reform in primary care was introduced by county coun-
cils and regions in Sweden. The reform enabled private
providers to freely establish clinics anywhere and list
patients. Concurrently with the reform, each county
council implemented different reimbursement systems
in primary care. With the increasing use of reimburse-
ment systems as a mean of achieving policy goals, there
is a need for empirical evidence to inform policy. The
aim of this review is to compare the different types of
reimbursement system in relation to socioeconomic and
racial inequalities in access, utilization and quality of care.
Methods
Inequity refers to systematic differences that is created
by unjust social processes and avoidable, and is
frequently distinguished from inequality [21]. However,
in this review we have chosen to use the terms inter-
changeably due to varying terminologies in the included
studies [22].
Search strategy
We conducted a systematic search of English-language
literature published between 1st of January 1980 and 30th
of September 2013 in two electronic databases: Web of
Science Core Collection and PubMed. The search string
was based on the PICO outline referenced by Petticrew
et al. and based on index terms and free text terms [23].
Primary health care, reimbursement system, equity and
Fig. 1 Conceptual framework for socioeconomic and racial inequity in health and health care. Adapted from Burström B. Int J of Health Services.
2009, 39(2):271–285 [6]
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their related synonyms built up the three main compo-
nents of the search string. The search strategy was
adapted between databases using the appropriate con-
trolled vocabulary when applicable. For details of the full
search strategy see Additional file 1.
Study selection
Studies with experimental or observational designs con-
ducted in primary care settings were included in this
review. Due to heterogeneity in health care context
between low-, middle- and high-income countries, only
studies from high-income countries based on the defin-
ition of the World Bank Group were selected for this re-
view. The three reimbursement systems assessed were
capitation, fee-for-service and pay-for-performance. All
patient-related outcomes were of interest. Only original
articles evaluating inequalities in relation to socioeco-
nomic position or race/ethnicity were considered for this
review; studies that addressed other dimensions of in-
equality such as age, sex and geographical distribution
were excluded. Other exclusion criteria included
publications that 1) lacked abstract in the databases; 2)
lacked a comparison group to the reimbursement sys-
tem(s) under study; 3) assessed a non-patient related out-
come, e.g. physician satisfaction and total healthcare costs;
and 4) when the type of reimbursement system could not
be determined from the information given in the article.
Duplicates from the two databases and studies that
clearly did not meet the inclusion criteria based on abstract
and title were removed through an initial screening. Full-
text articles were retrieved for the remaining search results
and were independently assessed for eligibility by two
authors (WT and JA); any disagreements were resolved
after discussion. If a longitudinal study analysed health care
inequalities between socioeconomic or ethnic groups
separately for each year but did not test if the inequalities
differed between years (i.e. difference-in-difference analysis),
we concluded that the reimbursement system had an
impact on inequity when within-year comparisons were
statistically significant for one year but not another. The
reference lists of the final selection of studies were
screened for articles of potential relevance.
Data extraction and critical appraisal
The quality of eligible studies was independently
assessed by two authors (WT and JA), using instruments
developed by Zaza et al. [24] and the University of Man-
chester [25]. The checklists were selected after reviewing
several tools for critical appraisal [26]. Strengths and
weaknesses of each study were discussed between the re-
viewers who assessed the papers and whenever disagree-
ment arose, a third reviewer (BB) was consulted. Overall
quality of the papers were divided into high, medium
and low based on assessments using the checklists. High
risk of bias, confounding and insufficient description of
data analysis were weighted more heavily than other
items on the checklists. Studies that were deemed to be
of low quality were excluded from the final synthesis.
Data from the final selection of studies were extracted ac-
cording to a predetermined data extraction form (see
Additional file 2). Findings from the studies were synthe-
sized in a narrative manner using an aggregative approach,
[27] and organized according to study outcome (access/
utilization of healthcare, quality of care/patient outcome)
and reimbursement system (capitation versus fee-for-
service, pay-for-performance). Within each category,
results from studies addressing the same medical condi-
tions were combined. Due to heterogeneity in context, de-
sign and outcome, statistical pooling of study results was
not possible.
Results
The search yielded 3,655 articles; 765 in Web of Science
and 2,890 in PubMed. Based on title and abstract, we iden-
tified 462 articles for full-text assessment and selected 82
for full-text review and critical appraisal. Finally, 22 articles
were included in the review based on inclusion/exclusion
criteria and quality assessment (Fig. 2). After full-text re-
view and critical appraisal, the most common reasons for
exclusion were 1) socioeconomic and racial/ethnic inequi-
ties were not addressed (n = 19); 2) the study lacked a com-
parison group for the reimbursement system (n = 12); 3)
reimbursement system could not be identified (n = 10); and
4) the research question did not match the aim of the
systematic review (n = 10). When two or more studies used
the same study population and addressed similar outcomes,
we included the most recent publication in this review,
which resulted in the exclusion of one study [28]. Two
more studies were excluded due to insufficient description
of data analysis, [7] and high risk of confounding (study
only controlled for sex) [29]. Summaries of each included
article are described in Additional file 3. We chose to keep
the terminology consistent with the referenced studies.
Thus, the terms race and ethnicity are presented inter-
changeably according to what was used by the author in
the articles.
Capitation versus Fee-for-service
Seven studies compared capitation to fee-for-service.
Most studies were from the US and addressed outcomes
related to health care access and utilization. Overall find-
ings from the studies are summarized in Table 1.
Patient satisfaction
One study assessed the impact of reimbursement system
on patient satisfaction. In a nationwide telephone survey
in the US, participants were asked to rank their last visit
to the primary care physician [30]. Minority groups
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(Black, Hispanic, and Native American/Asian/Pacific
Islander) reported lower satisfaction than whites in a
capitated insurance plan than in a non-capitated insur-
ance plans, but the difference was only significant for
physician’s ability to listen and to explain among English-
speaking Hispanics.
Access to healthcare
A US study found that there were less racial differences
in access and utilization of care among Medicaid benefi-
ciaries under managed care insurance plans (primarily
capitation) than under fee-for-service plans. Differences
in the proportion of enrolees who had a usual source of
care, had visited any doctor in the last year, or had used
ER in the last year, were significantly smaller between
blacks and whites on managed care than fee-for-service
plans. Similar results were observed for Hispanics in
regards to having a regular source of care [10]. The
beneficial impact of managed care on health care
inequalities were confirmed in another study of Medicare
patients using two different surveys. Compared to fee-for-
service, managed care increased the likelihood of
Hispanics having a usual source of care relative to white
enrolees, and blacks were more likely to have seen a
health professional recently. However, there was no
significant difference between managed care and fee-for-
service in regards to racial disparities in delaying care for
cost reasons, obtaining necessary medical care, or seeing a
Table 1 Summary of study results comparing capitation to
fee-for-service in regards to socioeconomic or racial inequity in
admissions for ambulatory care sensitive conditions, access to





Access to primary care Reference +
Patient satisfaction Reference (non-capitation) 0/-
“0” indicates no difference in inequity, “-“ indicates greater inequity, and “+”
indicates lesser inequity. “0/+” and “0/-“ indicate that results were mixed
depending on outcome and/or socioeconomic or ethnic/racial group. Values
from fee-for-service was used as the reference to which values from capitation
was compared
Fig. 2 Flow chart for selection of included studies
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medical specialist or general practitioner during the year
[31]. A survey study of 137 primary care practices in
Canada found that immigrants generally consumed more
primary care than Canadian-born participants. However,
among immigrants who had resided in the country less
than 5 years, those who attended fee-for-service practices
consumed a lesser amount of health care and experienced
inferior access to primary care than Canadian-born [32].
Ambulatory care sensitive conditions
Higher rates of ACSC admissions indicate limited access
to and lower quality of primary care [33]. Bindman et al.
compared ACSC admissions among Medicaid fee-for-
service enrolees to Medicaid managed care enrolees in
California between 1995 and 1999 [9]. The study found
that ACSC admission rates were lower in managed care
patients than fee-for-service patients, and the difference
in admission rates between reimbursement plans was
greater for African American, Asian and Latino groups
than whites. Distinctions were made between voluntary
and mandatory managed care enrolees, and the authors
noted that the lower rates of ACSC admissions persisted
in both groups and across minorities [9].
Pay-for-performance
A majority of the studies on pay-for-performance evalu-
ated the impact of QOF on quality of care. According to
this scheme, general practitioners in the UK are
rewarded for achieving predetermined targets that repre-
sents up to 25 % of the practices’ income [34]. The stud-
ies included in this review addressed disease-specific and
composite outcomes, and the overall findings from pre-
and post-implementation are summarized in Table 2.
Diabetes
Alshamsan et al. compared the change in diabetes-
related measurements for three time periods, i.e. pre-
QOF, immediately after the introduction of QOF, and
post-QOF [35]. The study noted that levels of mean
HbA1c, total cholesterol and mean systolic blood
pressure were decreasing in all ethnic groups (white,
black and South Asian) prior to QOF, and the new
scheme did not seem to add any additional benefit to
this downwards going trend. The existing ethnic dispar-
ities between whites, blacks and South Asians remained
largely unchanged after the introduction of QOF.
In a study by Millett et al., black Caribbean, black Afri-
can, Indian, Pakistani and Bangladeshi diabetic patients
achieved target HbA1c to a lower extent than whites.
They were also more often prescribed oral hypoglycemic
agents than whites, but were less likely to receive insulin.
The combination of these observations indicates that
suboptimal treatment of disease was more common in
these two minority groups [36]. No differences were,
however, observed for other ethnic groups. The rate of
prescription for lipid-lowering drugs and antihyperten-
sive drugs improved among diabetes patients across
ethnicities post-QOF, but it had little impact on reducing
pre-existing health inequalities. It is unclear if the
improvements in prescription rate could be attributed to
QOF alone, as the study did not estimate the underlying
trend of change in prescription rates over time [36].
In a Scottish study, diabetic patients from the least
deprived quintile were significantly more likely to
achieve target HbA1c levels compared to the most
deprived quintile, and this difference remained un-
changed after the introduction of QOF [37]. In contrast,
the proportion of diabetic patients that reached target
values of cholesterol was higher in the most deprived
quintile than in the least deprived quintile whereas no
difference was observed for target systolic blood pres-
sure. Overall, pay for performance seemed to have little
impact on socioeconomic inequalities in intermediate
clinical outcomes among diabetes patients [37].
According to a large cohort study from the UK, QOF
improved care for all diabetes patients (the proportion
of patients achieving target values of blood pressure,
total cholesterol and HbA1c exceeded the expected
levels based on extrapolation of prior trends), but the
pay-for-performance scheme seemed to have little im-
pact on reducing socioeconomic differences [38]. Differ-
ences in blood pressure levels between the least and
most deprived quintiles were attenuated after the intro-
duction of QOF, but the opposite trend was observed for
total cholesterol. No significant differences in HbA1c
levels between deprivation quintiles were seen either be-
fore or after QOF [38].
The same cohort was used to calculate quality of care
scores for diabetes patients, i.e. the number of achieved
indicators divided by the number of indicators applicable
to each patient [39]. The study found that diabetes care
was improving already prior to QOF, and that the
improvements accelerated during the first years of its
implementation. Prior to the scheme, practices in
Table 2 Summary of study results comparing inequity in the




Cardiovascular disease Reference 0/-
Respiratory disease Reference 0
Multiple diagnosis Reference 0
Preventive care Reference 0
“0” indicates no change in inequity, “-“ indicates increased inequity and “0/-“
indicate that results were mixed depending on outcome and/or socioeconomic
or ethnic/racial group. Values obtained after the implementation of
pay-for-performance were compared to the baseline values (reference)
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deprived areas provided overall slightly better diabetes
care compared to practices in affluent areas based on
QOF indicators. However, patients in deprived areas
gained less from QOF than patients from affluent areas
during the early years of the scheme as practices in
affluent areas seemed to have responded more quickly
to the financial incentives introduced by QOF [39].
Using national surveys from year 2003 and 2006 in the
UK, Crawley et al. compared the proportion of manual
and non-manual workers with coronary heart disease
(CHD), diabetes or hypertension that achieved target
values of blood pressure, blood glucose and cholesterol
[40]. Overall, the study found no difference in achieve-
ment of target levels for blood pressure or cholesterol
levels between manual and non-manual workers in 2003
and 2006. Among diabetes patients, the usage of antihy-
pertensive medicines, lipid-lowering drugs and oral
hypoglycemic agents did not differ between the groups
in either year. The proportion achieving target levels of
HbA1c was significantly lower among manual workers
than non-manual workers in 2003, but the gap was at-
tenuated in 2006 [40].
Cardiovascular disease
The proportion of patients that achieved target levels of
indicators for cardiovascular disease improved signifi-
cantly after the implementation of QOF in a serial cross-
sectional study [41]. White patients had their blood
pressure measured more frequently than south Asians
and achieved target levels of blood pressure to a greater
extent than blacks prior to QOF in 2003, but these dif-
ferences were attenuated after the reform in 2005. In
contrast, a higher proportion of south Asians achieved
target levels of blood pressure in 2003, and the differ-
ences increased in 2005. Ethnic disparities in most
cardiovascular indicators reduced after the introduction
of QOF, although the between-year difference was not
statistically significance [41].
Several studies assessed the impact of QOF on health
care inequalities between socioeconomic groups [40,
42–44]. The above referenced study by Crawley et al.
found that manual workers with CHD achieved blood
pressure target levels to a lower extent than non-manual
workers after the introduction of QOF, although no such
difference existed prior to the scheme [40]. There were
no significant differences in usage of antihypertensive
medication or lipid-lowering drugs and in achieving tar-
get cholesterol levels between the two groups [40]. In a
serial cross-sectional study of 310 general practices in
Scotland, CHD patients from the least deprived quintile
were more likely to receive influenza vaccination and to
have smoking status and blood pressure recorded but
less likely to receive anticoagulant therapy after the
introduction of QOF compared to the most deprived
quintile, while no such difference existed prior to QOF
[42]. There were differences in prescription rates of
ACE-inhibitors and beta-blockers between the
deprivation quintiles prior to QOF, and the scheme did
not change this difference [42]. Another study using
Scottish data from 2001 to 2006 did not identify any dif-
ference between deprivation quintiles in the proportion
of hypertensive patients achieving target values of blood
pressure or in prescription practices of antihypertensive
drugs, either before or after the introduction of QOF.
Overall, the study observed improvements for all
included parameters between 2001 and 2006, but did
not account for the underlying trend [43].
Another serial cross-sectional study used four incen-
tivized and ten non-incentivized quality indicators from
QOF to compare hypertension management in individ-
uals from areas with different deprivation scores
between 2003 and 2005 [45]. Patients from more
deprived areas achieved better results for one of the
incentivised quality indicators (last blood pressure 150/
90 or less) and two of the non-incentivised quality indi-
cators (serum creatinine and electrolytes; electrocardiog-
raphy) in 2003. Almost all indicators had improved by
2005; there were no differences by deprivation for the
incentivised indicators, but two non-incentivised indica-
tors (documented assessment of personal history of
peripheral vascular disease; documented assessment of
diabetes) differed significantly in favour of the more
deprived population. Thus, patients from more deprived
areas received at least equivalent quality of care as those
from less deprived areas before the introduction of QOF,
and QOF did not change this relation.
Simpson et al. studied patients with stroke or transient
ischemic attack and found that registration of smoking
status was more common in the most deprived than in
the least deprived quintile, but the relation was reversed
after the introduction of QOF [44]. Patients from the
most deprived quintile were also less likely to receive
anti-smoking advice or have their blood pressure
recorded post-QOF. No differences between deprivation
quintiles were observed for the use of MRI/CT scan,
anticoagulant therapy, influenza vaccination, registration
of cholesterol or proportion who achieved target choles-
terol levels, either pre- or post-QOF [44].
An interrupted time series study by Lee et al.
compared trends in mean blood pressure and mean total
cholesterol level before and after QOF in patients with
cardiovascular diseases [46]. QOF improved risk factor
control for CHD, stroke and hypertension for all ethnic
groups (black, south Asian and white), but did not
contribute significantly to narrowing the gap between
groups. In patients with coronary heart disease or stroke,
the differences in systolic blood pressure between blacks
and whites increased after the implementation of QOF.
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Respiratory diseases
In a serial cross-sectional study from the UK, the intro-
duction of QOF and new clinical guidelines for COPD
patients increased the registration of spirometry data
and use of combination inhalers for all patients, with no
differences between deprivation quintiles [47].
Multiple diagnoses
Bhalla et al. studied the impact of pay-for-performance in
a large, integrated health care delivery system in New York
City. The providers were evaluated on a number of quality
indicators that were grouped into five domains: diabetes,
CHD, heart failure, screening and prevention, and all care
[48]. Comparisons before and after the introduction of the
pay-for-performance program were made within each
racial group (American Indian/Alaskan Native, Asian,
African American/black, Native Hawaiian/Pacific Islander,
white and multiracial). The study found that the program
improved diabetes care, screening and prevention care,
and all care for all racial groups but Asians, who were
receiving standard of care treatment to a higher extent
already prior to the program. Analysis of interaction
between race and year revealed no difference between
groups in the effect of pay-for-performance. Caution
should be applied in generalizing the results, as the health
care system under study was more experienced in serving
minority communities, who often received higher quality
of care than their non-minority counterparts at start [48].
Dowd et al. compared mortality between HMO (capi-
tation) and fee-for-service Medicare enrolees in the US,
controlling for observed and unobserved confounders,
and found no effect of health plan on mortality by either
race/ethnicity (black vs. non-black, and Hispanic vs.
non-Hispanic) or education [49].
Preventive care
Based on cross-sectional data from Scotland in 2003–
2004 and 2006–2007, influenza immunization uptake in
the population aged ≥65 years and in clinical risk groups
increased after the introduction of QOF, but pre-existing
inequalities by deprivation status persisted [50].
A longitudinal cohort study of 4,284 patients in the
UK found a significant increase in the proportion of
diabetes patients whose smoking status was recorded
and who received smoking cessation advice after the
introduction of QOF [51]. With few exceptions, minority
groups (black African, black Carribean, Indian, Pakistani,
Bangladeshi) were significantly more likely to have their
smoking status recorded and had larger increase in reg-
istrations than white British from pre- to post-QOF.
There were no differences in the registration of smoking
status between deprivation quintiles, or in the propor-
tion receiving smoking cessation advice by ethnicity or
deprivation [51].
Discussion
This study did not find convincing evidence in favour of
one reimbursement system over another with respect to
impact on socioeconomic or racial inequalities in access,
utilization and quality of primary care.
This review adds to existing literature by addressing
the main types of reimbursement system and their
impact on socioeconomic or ethnic/racial health care in-
equalities. The included studies covered a wide spectrum
of outcomes, spanning over process measures to general
and disease-specific outcomes. The heterogeneity of the
outcomes complicates synthesis of results, since the
reimbursement system might have differential impact on
equity depending on the outcome under study. Patient
characteristics other than race/ethnicity or socioeco-
nomic status might also influence the effect of reim-
bursement systems and confound the results in these
studies. For example, Taggar et al. found that the
presence of chronic medical conditions was the
strongest predictor associated with recording smoking
status or cessation advice after the introduction of QOF
[52]. Furthermore, the effect of a given reimbursement
system might be context-specific and vary between
different health care systems, such as universal tax-
funded systems versus private health insurance systems.
Our review was dominated by studies from the US and
the UK, which limits generalizability and comparability
between studies since the structure of the health systems
differ widely between these countries. Additionally, stud-
ies from the US may be more vulnerable to selection
bias since patients choose their insurance plan. The
dominance of studies from the US and the UK might be
a result of the English language restriction in this review,
and studies from other countries addressing policy-
related research questions might be more commonly
published in the form of gray literature.
It is debatable whether the outcome measures in the
included studies are sensitive to socioeconomic and
racial inequalities. For example, changes in laboratory
values or blood pressure might be insufficient in captur-
ing inequalities in health care utilization and quality of
care. A reason for choosing these metrics could be data
accessibility; many of them are included in the QOF
scheme and tracked over time. However, this implies
that other important outcomes that could be suitable for
measuring inequity were neglected. For example, none
of the studies in this review addressed mental health that
disproportionately affects the lower socioeconomic
groups. Furthermore, none of the studies distinguished
between horizontal and vertical equity [53]. Observing
equal numbers of physician visits among different
groups might not imply equal health care utilization if
the need for health care differs between groups, and
similarly unequal numbers might not imply inequity. In
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most studies, a combination of different reimbursement
systems (capitation, fee-for-service and pay for perform-
ance) was applied, making it difficult to disentangle the
specific effect of one type of reimbursement system over
another. Additionally, adjustment of reimbursement by
e.g. age and socioeconomic factors in the population to
account for differential health care need between areas
was not accounted for and might have occurred in some
studies but not others, further contributing to the
complexity of reimbursement systems. Changes in re-
imbursement systems are often accompanied by the
implementation of other measures, such as new guidelines,
additional investments in healthcare and organizational
changes, which complicates causal inference. Thus, any
improvements observed may or may not be attributed to
the reimbursement system per se. A caveat of studying
health care reforms are the natural changes that would
have occurred over time regardless of the reform, which
could be addressed by taking time trends into account, but
few studies applied this method.
In spite of the lack of conclusive findings, this review
illustrates the complexity of reimbursement systems,
and the need of disentangling separate stages at which
inequalities in health care may appear. The study also
illustrates the lack of scientific evidence supporting the
impact of reimbursement systems on equity in primary
care, which in one sense is surprising given the many
reforms that involve changes in reimbursement systems.
The recent primary care reform in Sweden, with varia-
tions of the reimbursement system implemented in
twenty county councils and regions, would provide a
unique opportunity to study the effects of reimburse-
ment on equity in access and quality of care within the
same context and national health system. Ultimately, it
may be the effect of reimbursement system on resource
allocation that has the greatest impact on health care in-
equity. Barr et al. demonstrated how need-based re-
source allocation to deprived areas in the UK reduced
health inequities [54]. The rate of mortality amenable to
health care interventions declined faster in areas receiv-
ing the need-based resource allocation than in other
areas. This difference in the rate of decline was not ob-
served for all-cause mortality, suggesting that additional
resources to deprived areas were translated into health
care services that benefitted those with greater needs.
Hence, resource allocation that matches the increased
health care needs of underserved might have a greater
impact on health inequalities than the type of reimburse-
ment system per se.
Conclusions
The choice of reimbursement system seems to have
limited impact on socioeconomic or racial inequity in
access, utilization and quality of primary care. The lack
of conclusive evidence may be partly explained by the
complexity of reimbursement systems, the limitations in
study design and the context-specific findings. To reduce
health care inequalities, policy makers may consider
other strategies in addition to reforming the reimburse-
ment system, such as need-based resource allocation to
underserved populations. Further empirical studies are
warranted that address how resource allocation and
reimbursement systems should be designed in order to
best serve those with greater health care needs and
reduce health care inequalities.
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